levodopa

Poland

Drugs containing this active substance

  • DUODOPA

    The medicine is used to treat Parkinson's disease. It helps to increase dopamine levels in the body, which reduces symptoms such as tremors, stiffness, slowness of movement, and problems with maintaining balance.

    Form: gel, rectal

    Active substance Dosage
    levodopa 20 mg/ml
    carbidopa 5 mg/ml

    ATC: N04BA02

    Manufacturer: AbbVie Logistics B.V. HP Halden Pharma AS

  • Lecigon is used in the treatment of advanced Parkinson's disease, in situations where oral medications no longer provide sufficient effects.

    Form: gel, rectal

    Active substance Dosage
    levodopa 20 mg/ml
    carbidopa 5 mg/ml
    entacapone 20 mg/ml

    ATC: N04BA03

    Manufacturer: Bioglan AB STADA Arzneimittel AG

  • The medicinal product is used in the treatment of Parkinson's disease. Some of its forms are also indicated for the symptomatic treatment of restless legs syndrome (RLS), including in patients suffering from this syndrome in connection with renal failure requiring dialysis therapy.

    Form: capsules

    Active substance Dosage
    levodopa 200 mg
    benserazide 50 mg

    ATC: N04BA02

    Manufacturer: Roche Pharma AG

  • Madopar is used in the treatment of Parkinson's disease. Some of its formulations are also indicated for the symptomatic treatment of restless legs syndrome (RLS), including in patients suffering from this syndrome in connection with renal failure requiring dialysis therapy.

    Form: capsules

    Active substance Dosage
    levodopa 100 mg
    benserazide 25 mg

    ATC: N04BA02

    Manufacturer: Roche Pharma AG

  • The medicinal product is used in the treatment of Parkinson's disease and for the symptomatic treatment of restless legs syndrome (RLS), in this case in patients suffering from this syndrome in connection with renal failure requiring dialysis therapy.

    Form: suspension, oral, for preparation from tablets

    Active substance Dosage
    levodopa 100 mg
    benserazide 25 mg

    ATC: N04BA02

    Manufacturer: Roche Pharma AG

  • The medicine is used to treat Parkinson's disease, which is characterized, among other things, by slowed movements, muscle stiffness, and tremors.

    Form: tablets

    Active substance Dosage
    levodopa 200 mg
    benserazide 50 mg

    ATC: N04BA02

    Manufacturer: ROCHE FARMA, S.A.

  • The medicine is used to treat Parkinson's disease, which is characterized by, among other things, slowed movements, muscle stiffness, and tremors.

    Form: tablets

    Active substance Dosage
    levodopa 200 mg
    benserazide 50 mg

    ATC: N04BA02

    Manufacturer: Roche s.r.o.

  • The medicine is used to treat Parkinson's disease, which is characterized by, among other things, slowed movements, muscle stiffness, and tremors. Its purpose is to supplement the dopamine deficiency in the brain.

    Form: tablets

    Active substance Dosage
    levodopa 200 mg
    benserazide 50 mg

    ATC: N04BA02

    Manufacturer: Roche Farma S.A.

  • The medicine is used to treat Parkinson's disease, which is characterized by symptoms such as muscle stiffness, tremors, and slowed movements. Its purpose is to supplement the dopamine deficiency in the brain.

    Form: tablets

    Active substance Dosage
    levodopa 200 mg
    benserazide 50 mg

    ATC: N04BA02

    Manufacturer: Roche s.r.o.

  • Madopar is used in the treatment of Parkinson's disease. Some of its formulations are also indicated for the symptomatic treatment of restless legs syndrome (RLS), including in patients suffering from this syndrome in connection with renal failure requiring dialysis therapy.

    Form: capsules

    Active substance Dosage
    levodopa 50 mg
    benserazide hydrochloride 12.5 mg

    ATC: N04BA02

    Manufacturer: Roche Pharma AG

  • The medicinal product is used in the treatment of Parkinson's disease and in the symptomatic treatment of restless legs syndrome (RLS), in this case in patients with renal failure requiring dialysis therapy.

    Form: suspension, oral, for preparation from tablets

    Active substance Dosage
    levodopa 50 mg
    benserazide 12.5 mg

    ATC: N04BA02

    Manufacturer: Roche Pharma AG

  • Madopar is used in the treatment of Parkinson's disease and in the symptomatic treatment of restless legs syndrome (RLS), including in patients with renal failure requiring dialysis therapy.

    Form: capsules

    Active substance Dosage
    levodopa 100 mg
    benserazide hydrochloride 28.5 mg

    ATC: N04BA02

    Manufacturer: Roche Pharma AG

  • The medicine is used to treat the symptoms of Parkinson's disease and Parkinsonism. It helps alleviate movement problems (slowness, lack of coordination, tremors, muscle stiffness) resulting from a dopamine deficiency in the brain.

    Form: tablets

    Active substance Dosage
    levodopa 250 mg
    carbidopa 27 mg

    ATC: N04BA02

    Manufacturer: Lek Pharmaceuticals d.d.

  • Nakom mite is used to treat the symptoms of Parkinson's disease and Parkinsonism, such as muscle stiffness, tremors, and slow and uncoordinated movements.

    Form: tablets

    Active substance Dosage
    levodopa 100 mg
    carbidopa 27 mg

    ATC: N04BA02

    Manufacturer: Lek Pharmaceuticals d.d.

  • Parkador is used to relieve symptoms of Parkinson's disease in adults, such as slow and unsteady movements, muscle stiffness, and tremors.

    Form: tablets

    Active substance Dosage
    carbidopa monohydrate 13.5 mg
    levodopa 50 mg

    ATC: N04BA02

    Manufacturer: Orion Corporation Orion Pharma

  • The medicine is used to relieve symptoms of Parkinson's disease in adults, such as slow and unsteady movements, muscle stiffness, and tremors.

    Form: tablets

    Active substance Dosage
    carbidopa monohydrate 27 mg
    levodopa 100 mg

    ATC: N04BA02

    Manufacturer: Orion Corporation Orion Pharma

  • The medicine is used to relieve symptoms of Parkinson's disease in adults, such as slow and unsteady movements, muscle stiffness, and tremors.

    Form: tablets

    Active substance Dosage
    carbidopa monohydrate 27 mg
    levodopa 250 mg

    ATC: N04BA02

    Manufacturer: Orion Corporation Orion Pharma

  • The medicine is used to relieve symptoms of Parkinson's disease, such as tremors, muscle stiffness, and slow or unsteady movements.

    Form: suspension, oral, for preparation from tablets

    Active substance Dosage
    levodopa 5 mg
    carbidopa monohydrate 1.25 mg

    ATC: N04BA02

    Manufacturer: Desitin Arznemittel GmbH, Navamedic ASA, Orion Corporation, Orion Pharma

  • The medicine is used in the treatment of Parkinson's disease. It helps to replenish dopamine levels in the body, which reduces symptoms such as tremors, stiffness, slowed movement, and problems with maintaining balance.

    Form: solution for infusion

    Active substance Dosage
    levodopa 170 mg/ml
    carbidopa 9 mg/ml

    ATC: N04BA

    Manufacturer: AbbVie Deutschland GmbH & Co. KG

  • The medicine is used to treat Parkinson's disease (manifesting as tremors, slowed movements, and muscle stiffness) and to treat symptoms resembling Parkinson's disease (parkinsonism) resulting, for example, from poisoning or brain changes caused by atherosclerosis.

    Form: tablets

    Active substance Dosage
    levodopa 50 mg
    benserazide 12.5 mg

    ATC: N04BA02

    Manufacturer: Farmak International Sp. z o.o.

  • The medicinal product is used in the treatment of Parkinson's disease and symptoms resembling this disease (parkinsonism). It is also used in the treatment of restless legs syndrome (both of unknown cause and resulting from renal failure requiring dialysis).

    Form: tablets

    Active substance Dosage
    levodopa 100 mg
    benserazide 25 mg

    ATC: N04BA02

    Manufacturer: Farmak International Sp. z o.o.

  • The medicine is used in the treatment of Parkinson's disease (manifesting as tremors, slowed movements, and muscle stiffness) and in the treatment of symptoms resembling this disease (parkinsonism). It is also used in the treatment of restless legs syndrome (both of unknown cause and resulting from renal failure requiring dialysis).

    Form: tablets

    Active substance Dosage
    levodopa 200 mg
    benserazide 50 mg

    ATC: N04BA02

    Manufacturer: Farmak International Sp. z o.o.

  • Xevoben XR is used to treat Parkinson's disease and to treat restless legs syndrome (including that resulting from renal failure requiring dialysis), provided that the patient is already taking levodopa in combination with benserazide or carbidopa in an immediate-release form.

    Form: capsules, extended release, hard

    Active substance Dosage
    levodopa 100 mg
    benserazide 25 mg

    ATC: N04BA02

    Manufacturer: Farmak International Sp. z o.o.